Wilson, W H <br/><br/>
Phase I and pharmacokinetic study of the multidrug resistance modulator dexverapamil with EPOCH chemotherapy.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Aug 1995 
 - 1985-94 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article 
<br/><br/><label>ISSN: </label>0732-183X 
<br/><br/><label>Standard No.: </label>10.1200/JCO.1995.13.8.1985  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Cross-Over Studies<br/>Cyclophosphamide--administration & dosage<br/>Doxorubicin--administration & dosage<br/>Drug Resistance, Multiple<br/>Etoposide--administration & dosage<br/>Female<br/>Humans<br/>Hypotension--chemically induced<br/>Leukocyte Count--drug effects<br/>Lymphoma--blood<br/>Male<br/>Middle Aged<br/>Neutrophils<br/>Platelet Count--drug effects<br/>Prednisone--administration & dosage<br/>Sarcoma--blood<br/>Stereoisomerism<br/>Verapamil--administration & dosage<br/>Vincristine--administration & dosage